John Demsey Leaves Gap as Its Beauty Expansion Continues

John Demsey has left Gap after serving as executive director of beauty, a departure that removes a prominent industry operator while the retailer is still building the category. Gap confirmed the exit, while indicating that its beauty strategy and pilot program are continuing.

Demsey's role mattered because Gap recruited him to help turn beauty and accessories into a larger growth platform across its brands. In 2025, the company said it planned to test beauty products in roughly 150 Old Navy stores and described the U.S. beauty and personal-care market as a $100 billion opportunity. The market size is attractive, but Gap still has to prove that beauty can generate incremental traffic and profit inside apparel-led stores.

The departure does not by itself show that the strategy is failing. Executive transitions can reflect personal, organizational or performance factors, and the company has not disclosed evidence that the pilot is being canceled. The more useful test is whether Gap maintains the rollout, names clear operating leadership and reports measurable results from the stores involved.

That execution test comes against mixed companywide performance. Gap reported second-quarter net sales of $3.7 billion, down 2%, with comparable sales down 1% and online sales also down 1%. Profit exceeded expectations, but a new category needs to do more than add assortment. It should improve customer frequency, basket size or margin without creating excessive inventory complexity.

Beauty can offer repeat purchases and potentially attractive economics, yet success depends on product selection, merchandising and brand fit. An Old Navy shopper may respond differently from a Gap or Banana Republic customer, so a uniform rollout would carry risk.

Investors should look for three concrete signs: whether the 150-store pilot remains on schedule, who now owns the program and whether management discloses sales or traffic lift. Demsey's departure raises the execution burden, but the commercial case for testing beauty remains intact until store data show otherwise.